Washington, United States
Curio LV, founded in 2021, is positioning itself at the forefront of the 2nd Nuclear Era by tackling critical global issues through innovation in nuclear technology. The company is rooted in the belief that a closed nuclear cycle is imperative for the future, providing clean energy solutions while simultaneously enabling the United States to potentially become an energy exporter.
With a focus on ESG, Energy, and Oil and Gas sectors, Curio LV aims to combine environmental sustainability with advanced medical solutions, offering next-generation cancer therapies at affordable prices. This strategic vision sets them apart in an increasingly competitive and environmentally-conscious market.
Headquartered in the United States, Curio LV recently secured a $7.50M Seed Round investment on 18 April 2024, led by Synergos Holdings. This funding is expected to bolster their innovative endeavors, enabling the company to expand its technological capabilities and market reach.
